Victor R. Lavis, M.D.
Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Clinical Professor, Endocrine Neoplasia and HD, University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Clinical Professor, Endocrine Neoplasia and HD, The University of Texas MD Anderson Cancer Center, Houston, Texas
Professor (voluntary), Internal Medicine, The University of Texas Medical School at Houston, Houston, TX
Clinical Interests
For general clinic information and referrals, please visit the Department of Endocrine Neoplasia and Hormonal Disorders' contact information webpage at:
Contact Information
Education & Training
Degree-Granting Education
| 1962 | Stanford University, Stanford, California, US, MD |
| 1959 | Stanford University, Stanford, California, US, Biological Sciences, AB |
Postgraduate Training
| 1969-1970 | Trainee of Research Training Unit, Endocrinology & Metabolism, University of Washington School of Medicine, Seattle, Washington |
| 1969-1970 | Special Fellow of NIH, Endocrinology, University of Washington School of Medicine, Seattle, Washington |
| 1967-1969 | Postdoctoral Fellow, Endocrinology and Metabolism, University of Washington School of Medicine, Seattle, Washington |
| 1966-1967 | Resident, Internal Medicine, UCLA School of Medicine, Los Angeles, California |
| 1962-1964 | Intern and Assistant resident, Internal Medicine, Harvard Medical Service, Boston City Hospital, Boston, Massachusetts |
Licenses & Certifications
| 2018 | California state retired physician license |
| 2008 | American Board of Internal Medicine, Endocrinology and Metabolism |
| 1976 | Texas state license to practice medicine |
| 1969 | American Board of Internal Medicine |
| 1968 | Washington State License |
| 1964 | California state license to practice medicine |
Experience & Service
Faculty Academic Appointments
Professor, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2010
Professor, Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2021
Professor, Department of Internal Medicine, Division of Endocrinology, The University of Texas Medical School at Houston, Houston, TX, 1996 - 2007
Member of the Faculty, Graduate School of Biomedical Sciences, The University of Texas at Houston Health Science Center, Houston, TX, 1977 - 1994
Associate Professor, Department of Internal Medicine, Division of Endocrinology, The University of Texas School of Medicine at Houston, Houston, TX, 1976 - 1996
Assistant Professor, Department of Medicine, Division of Endocrinology, University of Washington School of Medicine, Seattle, WA, 1971 - 1976
Instructor, Department of Medicine, Division of Endocrinology, University of Washington School of Medicine, Seattle, WA, 1969 - 1971
Administrative Appointments/Responsibilities
Program Director, Internal Medicine Residency Training, The University of Texas Medical School at Houston, Houston, TX, 1985 - 1998
Program Director, Diabetes Research Training Program (NIH Supported), The University of Texas at Houston, Houston, TX, 1978 - 1986
Assistant Program Director, Clinical Research Center, University of Washington Hospital, Seattle, WA, 1971 - 1976
Other Professional Positions
Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2013
Faculty Senate, The University of Texas Medical School, Houston, Houston, TX, 1978 - 1986
LCDR(R)(T), Internist, Internal Medicine, U.S. Public Health Service Hospital, Detroit, Michigan, 1964 - 1966
Intramural Institutional Committee Activities
Member, Internal Medicine Center Steering Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2018
Member, Internal Medicine Residency Steering Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2020
member, MDACC Department of Endocrine Neoplasia and Hormonal Disorders, Departmental Executive Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2021
Member, The University of Texas MD Anderson Cancer Center, Clinical Affairs Subcommittee of Faculty Senate, The University of Texas MD Anderson Cancer Center, 2010 - 2013
Member, MDACC Department of Endocrine Neoplasia and Hormonal Disorders, Departmental Mentoring Oversight Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2012
Member, The University of Texas MD Anderson Cancer Center, Point of Care Testing Committee, The University of Texas MD Anderson Cancer Center, 2008 - Present
Member, The University of Texas MD Anderson Cancer Center, Division of Internal Medicine Grand Rounds Planning Committee, The University of Texas MD Anderson Cancer Center, 2007 - Present
Co-leader, The University of Texas MD Anderson Cancer Center, Inpatient Diabetes Clinical Effectiveness Work Group, The University of Texas MD Anderson Cancer Center, 2007 - 2020
member, MDACC Faculty Senate, The University of Texas MD Anderson Cancer Center, 2007 - 2013
Member, MDACC- UTMSH Center for Clinical and Translational Sciences, Scientific Advisory Committee, The University of Texas MD Anderson Cancer Center & University of Texas, Houston Medical School, 2007 - 2011
member, UTHSCH Search Committee for Metabolism Director of Institute of Molecular Medicine, The University of Texas Health Sciences Center, Houston, 2006 - 2007
chair, UTMSH Curriculum Subcommittee for Evaluation of 2nd Year Curriculum, The University of Texas Medical School, Houston, 2005
member, UTHSCH Research Conflict of Interest Committee, The University of Texas Health Science Center, Houston, 2004 - 2006
member, UTMSH Curriculum Subcommittee on Organization of 3rd and 4th Year Curriculum, The University of Texas, Houston Medical School, 2004 - 2006
member, UTMSH Task Force on Student Performance on USMLE Step 1, The University of Texas, Houston Medical School, 2004 - 2005
chair, UTMSH Curriculum Subcommittee for Internal Review of Obstetrics and Gynecology Residency, The University of Texas, Houston Medical School, 2002 - 2003
chair, UTMSH Curriculum Subcommittee for Evaluation of 2nd Year Curriculum, The University of Texas, Houston Medical School, 2002 - 2003
member, UTMSH Curriculum Committee, The University of Texas, Houston Medical School, 2000 - 2006
principal reviewer for pediatric clerkship, UTMSH Curriculum Committee, The University of Texas, Houston Medical School, 2000 - 2001
chair, UTMSH Department of Internal Medicine Committee for Development of Written Curriculum for Internal Medicine Residency, The University of Texas, Houston Medical School, 1998 - 1999
interviewer, UTMSH Admissions Committee, The University of Texas, Houston Medical School, 1996 - 2006
member, UTMSH Department of Internal Medicine Committee on Evaluation of Residents, The University of Texas, Houston Medical School, 1995 - 2006
chair, UTMSH Endocrinology and Reproductive Biology Working Group for Development of the New 2nd Year Curriculum, The University of Texas, Houston Medical School, 1994 - 1999
member, UTMSH Internal Review Committee for Department of Emergency Medicine, The University of Texas, Houston Medical School, 1993 - 1994
member, UTMSH Graduate Medical Education Committee, The University of Texas, Houston Medical School, 1991 - 1998
chair, UTMSH Graduate Medical Education Committee, The University of Texas, Houston Medical School, 1991 - 1993
member, UTMSH Search Committee for Director of Pediatric Endocrinology, The University of Texas, Houston Medical School, 1991 - 1992
member, UTMSH Search Committee for Director of Emergency Medicine, The University of Texas, Houston Medical School, 1991
member, Steering Committee for UTMSH Self-Study, The University of Texas, Houston Medical School, 1989 - 1990
member, UTMSH Self Study Task Force, The University of Texas, Houston Medical School, 1989
chair, UTMSH, MSRDP Scholarship Grant Committee, The University of Texas, Houston Medical School, 1987 - 1989
chair, UTMSH Department of Internal Medicine, Medical Care Committee, The University of Texas, Houston Medical School, 1987 - 1989
member, UTMSH Biomedical Research Support Committee, The University of Texas, Houston Medical School, 1987 - 1989
member, UTMSH Department of Internal Medicine, Promotions Committee, The University of Texas, Houston Medical School, 1986 - 1987
member, UTMSH Committee on Committees, The University of Texas, Houston Medical School, 1986 - 1987
chair, UTMSH Department of Internal Medicine, Resident Selection & Evaluation Committee, The University of Texas, Houston Medical School, 1985 - 1998
chair, Pharmacy and Therapeutics Committee, Hermann Hospital, Hermann Hospital, 1985 - 1986
member, UTMSH Self Study Task Force, The University of Texas, Houston Medical School, 1985
chair, UTMSH Faculty Committee for Review of Surgery Clerkship, The University of Texas, Houston Medical School, 1984 - 1986
member, UTMSH Department of Internal Medicine, Educational Program Committee, The University of Texas, Houston Medical School, 1983 - 1991
member, UTMSH Curriculum Committee, The University of Texas, Houston Medical School, 1983 - 1986
member, Pharmacy and Therapeutics Committee, Hermann Hospital, Hermann Hospital, 1982 - 2007
member, UTHSCH Radiation Safety Committee, The University of Texas Health Science Center, Houston, 1982 - 1987
chair, UTMSH Biomedical Research Support Committee, The University of Texas, Houston Medical School, 1982 - 1983
member, UTMSH Internal Review Committee for Department of Reproductive Medicine and Biology, The University of Texas, Houston Medical School, 1982
member, UTMSH Educational Policy Committee, The University of Texas, Houston Medical School, 1981 - 1982
member, MSRDP Scholarship Grant Committee, The University of Texas, Houston Medical School, 1980 - 1989
member, UTMSH Biomedical Research Support Committee, The University of Texas, Houston Medical School, 1980 - 1983
member, UTHSCH Ambulatory Care Center Task Force, The University of Texas Health Science Center, Houston, 1980 - 1981
member, UTMSH Committee on Committees, The University of Texas, Houston Medical School, 1979 - 1980
member, UTMSH Search Committee for Chairman of Physiology, The University of Texas, Houston Medical School, 1979
member, Committee for Protection of Human Subjects, The University of Texas, Houston Health Sciences Center, 1977 - 1980
student advisor, UTMSH, The University of Texas, Houston Medical School, 1977 - 2007
member, Medical Records Committee, Hermann Hospital, Hermann Hospital, 1977 - 1981
member, UTMSH Self Study Task Force, The University of Texas, Houston Medical School, 1977
Extramural Institutional Committee Activities
member, Scientific Advisory Committee, Texas Medical Center Library, Texas Medical Center Library, 1979 - 1982
Editorial Activities
Service on Editorial Board, Editorial Board, Diabetes, 1989 - 1992
Service on Editorial Board, Editorial Board, Clinical Diabetes, 1985 - 1987
Co-editor, Therapeutics Update, Hermann Hospital, 1983 - 1984
Honors & Awards
| 2011 | Physician of the Year, Houston Chapter of The American Diabetes Association |
| 2005 | Distinguished Physician Award, Memorial Hermann Hospital |
| 2005 | Herbert and Margaret DuPont Master Clinical Teacher Award, University of Texas, Houston Medical School |
| 1966 - 1967 | Harwood Foundation Fellowship, UCLA Medical School |
| 1961 | Alpha Omega Alpha, Stanford Medical School |
| 1960 | Roche Award, Stanford Medical School |
| 1959 | Phi Beta Kappa, Stanford University |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2017. Effect of diabetes on management of cancer. Internal Medicine Grand Rounds. Houston, TX, US.
- 2016. Too Sweet? Challenges in Glycemic Management. Internal Medicine Grand Rounds. Houston, TX, US.
- 2016. Issues in diabetes. Internal Medicine Grand Rounds, US.
- 2015. Clinicopathologic conference: A woman with hypothyroidism and melanoma. Internal Medicine Grand Rounds, US.
- 2015. Clinicopathologic conference: Type 1 diabetes in an adult. Internal Medicine Grand Rounds, US.
- 2013. Clinicopathologic conference: Type 2 diabetes, breast cancer and hypopituitarism. Internal Medicine Grand Rounds, US.
- 2013. Is Insulin Bad for Your Heart?. Internal Medicine Grand Rounds, US.
- 2011. Perioperative management of hyperglycemia. Anesthesia Grand Rounds, US.
- 2010. Perioperative management of hyperglycemia. Anesthesia Grand Rounds, US.
- 2010. Glycemia and cardiovascular disease. Internal Medicine Grand Rounds, US.
- 2010. Diabetes treatment and coronary artery disease. Invited. Preventive Cardiology Symposium, US.
- 2010. Results of the BARI 2D trial of diabetes and coronary artery disease. Invited. Cardiology Grand Rounds, US.
- 2010. Cardiovascular effects of diabetes medicines. Invited. Endocrine Grand Rounds, US.
- 2009. Results of the BARI 2D trial of diabetes and coronary artery disease. Invited. Internal Medicine Grand Rounds, US.
- 2007. Heart Failure and Diabetes. Invited. MD Anderson/Mayo Symposium: Diabetes Mellitus in People with Serious Illnesses. Houston, Texas, US.
- 2007. "Heart Failure and Diabetes". Invited. Grand Rounds, US.
Regional Presentations
- 2007. "Heart Failure and Diabetes" MD Anderson Cancer Center/ Mayo Symposium, Diabetes Mellitus in People with Serious Illnesses: Beyond Sick Day guidelines. Conference. MD Anderson Cancer Center/ Mayo Symposium, Diabetes Mellitus in People with Serious Illnesses: Beyond Sick Day guidelines. Houston, TX, US.
- 2007. "Heart Failure and Diabetes" MD Anderson Cancer Center/ Mayo Symposium, Diabetes Mellitus in People with Serious Illnesses: Beyond Sick Day guidelines. Conference. "Heart Failure and Diabetes" MD Anderson Cancer Center/ Mayo Symposium, Diabetes Mellitus in People with Serious Illnesses: Beyond Sick Day guidelines, US.
National Presentations
- 2017. The Effect of Diabetes on the Management of Cancer. Conference. Symposium on Diabetes and Cancer 2017: Novel Links and Treatments. New York, NY, US.
Grant & Contract Support
| Date: | 2001 - 2008 |
| Title: | BARI 2D Trial of type 2 diabetes and coronary artery disease. Local funding $20,000 startup; $50,000 recruitment supplement; $2,000 per subject per year |
| Funding Source: | NIH |
| Role: | Site co-Principal Investigator |
Selected Publications
Peer-Reviewed Articles
- Gandhi A, Jeun R, Wang Z, Khan S, Best C, Lavis V, Thosani S. Etiologies and Outcomes of Diabetic Ketoacidosis in Cancer Patients: A Retrospective Analysis. Cancers 17(17):2728, 2025. e-Pub 2025. PMID: 40940823.
- Lavis VR, Iyer PC, Best C, Lavis V, Varghese JM, Yeduduri S, Brady V, Glitza Oliva IC, Dadu R, Milton DR, Brock K, Thosani S. Clinical outcomes of immune checkpoint inhibitor diabetes mellitus at a comprehensive cancer center. Immunotherapy 15(6):417-428, 2023. e-Pub 2023. PMID: 37013834.
- Bedrose S, Turin CG, Lavis VR, Kim ST, Thosani SN. A case of acquired generalized lipodystrophy associated with pembrolizumab in a patient with metastatic malignant melanoma. AACE Clinical Case Reports 6(1):e40-e45, 2020. e-Pub 2020.
- Iyer PC, Cabanillas ME, WaguespackSG, et al. Immune-Related Thyroiditis with Immune Checkpoint Inhibitors. Thyroid 28(10):1243-1251, 2018. e-Pub 2018. PMID: 30132401.
- Brady V, Thosani S, Zhou S, Bassett R, Busaidy NL, Lavis V. Safe and effective dosing of basal-bolus insulin in patients receiving high-dose steroids for hyper-cyclophosphamide, doxorubicin, vincristine, and dexamethasone chemotherapy. Diabetes Technol Ther 16(12):874-9, 2014. e-Pub 2014. PMID: 25321387.
- Vu K, Busaidy N, Cabanillas ME, Konopleva M, Faderl S, Thomas DA, O'Brien S, Broglio K, Ensor J, Escalante C, Andreeff M, Kantarjian H, Lavis V, Yeung SC. A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk 12(5):355-62, 2012. e-Pub 2012. PMID: 22658895.
- Pop-Busui R, Lombardero M, Lavis V, Forker A, Green J, Korytkowski M, Sobel BE, Jones TL, Group BS. Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study). Am J Cardiol 104(1):52-8, 2009. e-Pub 2009. PMID: 19576321.
- Davis A, Goel S, Picolos M, Wang M, Lavis V. Pituitary apoplexy after leuprolide. Pituitary (3)(9):263-5, 2006. e-Pub 2006. PMID: 16832587.
- Picolos MK, Lavis VR, Orlander PR. Milk-alkali syndrome is a major cause of hypercalcaemia among non-end-stage renal disease (non-ESRD) inpatients. Clin Endocrinol (Oxf) 63(5):566-76, 2005. e-Pub 2005. PMID: 16268810.
- Rodriguez T, Lavis VR, Meininger JC, Kapadia AS, Stafford LF. Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone. Endocr Pract 11(4)(4):223-33, 2005. e-Pub 2005. PMID: 16006298.
- Picolos MK, Sims CR, Mastrobattista JM, Carroll MA, Lavis VR. Milk-alkali syndrome in pregnancy. Obstet Gynecol 104(5 Pt 2):1201-4, 2004. e-Pub 2004. PMID: 15516453.
- Boccalandro C, De Mattia F, Guo DC, Xue L, Orlander P, King TM, Gupta P, Deen PM, Lavis VR, Milewicz DM. Characterization of an aquaporin-2 water channel gene mutation causing partial nephrogenic diabetes insipidus in a Mexican family: evidence of increased frequency of the mutation in the town of origin. J Am Soc Nephrol 15(5)(5):1223-31, 2004. e-Pub 2004. PMID: 15100362.
- Boccalandro C, Lopez L, Boccalandro F, et al. Electrocardiographic changes in thyrotoxic periodic paralysis. Analysis of 6 cases. Am. J. Cardiol 91(6):775-777, 2003. e-Pub 2003. PMID: 12633825.
- Boccalandro, C, Lopez-Penabad, L, Boccalandro, F, andLavis, V. Ventricular fibrillation in a young Asian man. Lancet 361(9367):1432, 2003. e-Pub 2003. PMID: 12727398.
- Brod SA, Atkinson M, Lavis VR, Brosnan PG, Hardin DS, Orlander PR, Nguyen M, Riley WJ. Ingested IFN-alpha preserves residual beta cell function in Type 1 diabetes. J Interferon Cytokine Res 21(12):1021-1030, 2001. e-Pub 2001. PMID: 11798459.
- Lavis VR, D'Souza D, Brown SD. Decompensated diabetes. New features of an old problem. Circulation 90(6):3108-12, 1994. e-Pub 1994. PMID: 7994861.
- Lowry PA, Semenkovich JW, Scott LD, Zeck OF, Desai A, Lavis VR. Administration of 131 I capsule via nasogastric tube in an uncooperative patient with Graves disease. AJR Am J Roentgenol 155(3)(3):611-612, 1990. e-Pub 1990. PMID: 2117363.
- Lavis VR, Lee DP, Shenolikar S. Evidence that forskolin binds to the glucose transporter of human erythrocytes. J Biol Chem 262(30):14571-5, 1987. e-Pub 1987. PMID: 3667590.
- Lavis VR, Davenport R, Pontier P, Thompson WJ, Strada SJ. Cyclic AMP does not modulate hexose uptake of serum-deprived BHK-21 fibroblasts. J Cell Physiol 112(3):373-375, 1982. e-Pub 1982. PMID: 6182151.
- Thompson WJ, Ross CP, Strada SJ, Hersh EM, Lavis VR. Comparative analyses of cyclic adenosine 3':5'-monophosphate phosphodiesterases of human peripheral blood monocytes and cultured P388D1 cells. Cancer Res 40(6):1955-60, 1980. e-Pub 1980. PMID: 6154534.
- Lavis VR, Thompson WJ, Strada SJ. Effects of insulin on glycogen metabolism of serum-deprived BHK-21 fibroblasts. J Cell Physiol 103(1):55-62, 1980. e-Pub 1980. PMID: 6253506.
- Lavis VR, Strada SJ, Ross CP, Hersh EM, Thompson WJ. Comparison of the responses of freshly isolated and cultured human monocytes and P388D1 cells to agents affecting cyclic AMP metabolism. J Lab Clin Med 96(3):551-562, 1980. e-Pub 1980. PMID: 6156975.
- Ross JB, Rousslang KW, de Haën C, Lavis VR, Deranleau DA. [12-Homoarginine] glucagon: synthesis and observations on conformation, biological activity, and copper-mediated peptide cleavage. Biochim Biophys Acta 576(2):372-84, 1979. e-Pub 1979. PMID: 427194.
- Lavis VR. Hexokinase isozymes of normal human subcutaneous adipose tissue. Metabolism 27(9):1101-1108, 1978. e-Pub 1978. PMID: 682973.
- Lavis VR, Williams RH. Comparison of the lipolytic effects of insulin and proinsulin on isolated fat cells. Diabetes 24(2):238-239, 1975. e-Pub 1975. PMID: 1123111.
- Thompson WJ, Johnson DG, Lavis VR, Williams RH. Effects of secretin on guanyl cyclase of various tissues. Endocrinology 94(1):276-278, 1974. e-Pub 1974. PMID: 4148764.
- Sakai T, Lavis VR, Ensinck JW, Williams RH. Effects of extracellular proteases on incorporation of amino acids into protein by isolated rat tissues. Proc Soc Exp Biol Med 145(3):1096-1099, 1974. e-Pub 1974. PMID: 4206513.
- Sakai T, Thompson WJ, Lavis VR, Williams RH. Cyclic nucleotide phosphodiesterase activities from isolated fat cells. Correlation of subcellular distribution with effects of nucleotides and insulin. Arch Biochem Biophys 162(2):331-339, 1974. e-Pub 1974. PMID: 4366367.
- Lavis, VR, Williams, RH. The lipolytic effects of high concentrations of insulin on isolated fat cells Enhancement of the response to lipolytic hormones. Diabetes 22:629-636, 1973. e-Pub 1973.
- Sakai T, Lavis VR, Williams RH. Treatment of isolated fat cells with trypsin inhibits the effects of insulin on incorporation of leucine into protein. Diabetologia 9(5):422-425, 1973. e-Pub 1973. PMID: 4773202.
- Sakai T, Lavis VR, Williams RH. Incorporation of leucine into protein by isolated fat cells; Effects of agents which stimulate glucose metabolism and inhibit lipolysis. Biochem. Pharmacol 22:2761-2762, 1973. e-Pub 1973.
- Lavis VR, Ensinck JW, Williams RH. Effects of insulin and proinsulin on isolated fat cells and hemidiaphragms from rats. Endocrinology 87(1):135-42, 1970. e-Pub 1970. PMID: 5445361.
- Lavis VR, Williams RH. Studies of the insulin-like actions of thiols upon isolated fat cells. J Biol Chem 245(1):23-31, 1970. e-Pub 1970. PMID: 5411544.
- Lavis VR, Kitabchi AE, Williams RH. In Vitro lipid peroxidation in isolated fat cells of rats: Correlation with total lipolysis, glucose utilization, and dietary tocopherol. J. Biol. Chem 244(16):4382-4386, 1969. e-Pub 1969.
- Kalman SM, Lombrozo ME, Lavis VR. Effect of estradiol on the transfer rate of small molecules into the rat uterus. Science 134:1272, 1961. e-Pub 1961.
Invited Articles
- Best CJ, Thosani S, Ortiz M, Levesque C, Varghese S, Lavis V. Co-managing Patients with Type 1 Diabetes and Cancer. Current Diabetes Reports 16(8):73, 2016. e-Pub 2016. PMID: 27319323.
Review Articles
- Leichman JG, Lavis VR, Aguilar D, Wilson CR, Taegtmeyer H. The metabolic syndrome and the heart; a considered opinion. Clin Res Cardiol 95(supplement1):i134-i141, 2006. e-Pub 2006. PMID: 16598541.
- El-Muayed M, Lavis VR, Safi HJ, Fuentes F. Use of glitazones in cardiac patients; a case for B-type natriuretic peptide monitoring?. Am J Cardiol 93(5):600-602, 2004. e-Pub 2004. PMID: 14996586.
Professional Educational Materials
- Lavis V. Three study cases for UTMSH second-year Problems-Based Learning course, 2006.
- Lavis V. Online Guide to Treatment of Diabetic Ketoacidosis in Adults, 2006.
- . Teaching Aids on UTMSH Endocrinology website at http://www.uth.tmc.edu/schools/med/imed/endo/patientcare.html, 2006.
Editorials
- Lavis VR. The Highs and Lows of Hemoglobin A1c. Cardiology 134(3):325-6, 2016. PMID: 26974562.
Abstracts
- Jeun R, Lavis VR, Thosani S. Diabetic Ketoacidosis With Alpelisib. Annual meeting of The Endocrine Society 5(Suppl. 1):A376-7, 2021. e-Pub 2021.
- Jeun R, Best C, Iyer P, Lavis VR, Varghese JM, Glitza-Oliva I, Dadu R, Thosani S. Immune Checkpoint Inhibitor Mediated Insulin Dependent Diabetes: Observations at a Cancer Center. Annual meeting of The Endocrine Society 5(Suppl. 1):A415-6, 2021. e-Pub 2021.
- Wilson M, Zaghian M, Rice J, Warren ML, Estrella J, Parikh M, Stone D, Verallo C, Kaur H, Lopez K, Fajardo J, Gaeta S, Grami P, Lavis V, Best C, Thosani S. Improving Identification and Documentation of Patients Utilizing Insulin Pumps at MD Anderson Cancer Center. Diabetes Technology Society Hospital diabetes Meeting, 2020.
- Iyer P, Best C, Lavis VR, Varghese JM, Glitza Oliva IC, Dadu R, Thosani S. Checkpoint Inhibitor Mediated Insulin Dependent Diabetes: A Cancer Center Experience. Annual Meeting of Endocrine Society, 2018.
- Cillo M, Thosani S, Lavis VR, Mohamed A, Morrison W. External Radiation Therapy: A Rare Cause of Thyroiditis, 2017. e-Pub 2017.
- Brady V, Crawford K, Levesque C, Atmar J, Thosani S, Lavis V. Steroid Induced Hyperglycemia in Patients with Mantle Cell Lymphoma Treated at MDACC, 2014. e-Pub 2014.
- Thosani S, Brady V, Lavis V, Busaidy N. Safe and Effective Dosing of Basal-Bolus Insulin in Patients Receiving High-Dose Steroids for Hyper-CVAD Chemotherapy, 2014. e-Pub 2014.
- Brady VJ, Crawford K, Levesque C, Lavis VR, Thosani S. Attainment of Lipid Targets in MDACC Patients with Diabetes Mellitus, 2013. e-Pub 2013.
- Lavis VR, Brady VJ, Crawford K, Levesque C. What Keeps People From Taking Metformin?, 2012. e-Pub 2012.
- Thosani S, Waguespack S, Lavis V, Jimenez C. Interleukin-2 Therapy and the Extremes of Autoimmune Thyroid Disease, 2011. e-Pub 2011.
- Lavis VR, Lombardero MS, Albert SG, Genuth S, Jenkins M, Krishnaswami A, Nesto R, Richardson S. The BARI 2D Investigators. Effect of insulin-sensitizing treatment on cardiovascular outcomes in people taking insulin at baseline of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) study, 2010. e-Pub 2010.
- Shah P, Busaidy NL, Kapoor S, Sherman SI, and Lavis VR. "Steroid Hyperglycemia" Is Not Benign, 2009. e-Pub 2009.
- Brady V, Crawford KM, Levesque C, Owens A, Busaidy N, Lavis V. Increased Insulin Requirements in Patiens with Diabetes Receiving Hyper-CVAD, 2008. e-Pub 2008.
- Brady V, Crawford K, Levesque C, Owens A, Lavis V Busaidy N. Increased insulin requirements in patients with diabetes receiving hyper-CVad. Abstract 24-254, 2008. e-Pub 2008.
- Crawford K, Levesque C, Brady V, Owens A, Busaidy N, Lavis V. Glycemic management of hospitalized patients receiving tube feeding in a cancer center. Abstract 19-196, 2008. e-Pub 2008.
- Crawford KM, Levesque C, Brady V, Owens A, Busaidy N, Lavis V. Increased Insulin Requirements in Patients with Diabetes Receiving Tube Feeding, 2008. e-Pub 2008.
- Shah P, Cui J, Busaidy NL, Sherman SI, Lavis VR. Why is "new" hyperglycemia dangerous in the cancer hospital?, 2008. e-Pub 2008.
- Vu K, Lavis V, Strom S, Faderl S, Konopleva M, Thomas D, Gruschkus J, Hubbard M, Andreeff M, Kantarjian H. Hyperglycemia and obesity in patients (pts) with acute lymphoblastic leukemia (ALL): association with prevalence, response, and survival, 2007. e-Pub 2007.
- Kapoor S, Cui J, Busaidy N, Lavis V, Shah P. Recognized and unrecognized hyperglycemia in cancer inpatients, 2007. e-Pub 2007.
- Escobedo, J, Lavis, VR, Lombardero, M, Buitron, V, Zonszein J. Patients with type 2 diabetes suffering from coronary artery disease have better lipid and glycemic control than reported in NHANES 1999-2002, but remain undertreated: The BARI-2D Study, 2007. e-Pub 2007.
- Vu KD, Strom S, Konopleva M, Thomas D, Faderl S, Hubbard J, Andreeff M, Kantarjian H, Lavis V. . Prevalence of hyperglycemia and obesity in patients (pts) with newly diagnosed acute lymphoblastic leukemia (ALL), 2007. e-Pub 2007.
- Prasad A, Eng C, Shah P, Lavis V, Busaidy NL. Oncologic outcomes in diabetic patients with colon cancer, 2007. e-Pub 2007.
- Boccalandro C, Rivera-Davila M, Nelson SC, Palacios GA, Lavis VR. Extreme insulin resistance induced by total parenteral nutrition in a woman with diabetes, HIV lipodystrophy and a kidney transplant, 2007. e-Pub 2007.
- Picolos, MK, Lavis, VR, Orlander, P. Milk-alkali syndrome is a major cause of hypercalcemia among inpatients, 2004. e-Pub 2004.
- Picolos, M, Sims, C, Carroll, M, Fonseca, O, Lavis A, V. Milk-alkali syndrome in pregnancy, 2004. e-Pub 2004.
- IIiescu, Stack, Scott A, G, Underwood, C, Fulton, S, Camarillo, C, Olivares, M, Dasher, K, Santamaria, A, Salas, J, Smalling, R, Lavis, V, Fuentes, R. Association of traditional coronary risk factors with coronary artery disease among patients with diabetes; an angiographic study, 2003. e-Pub 2003.
- Boccalandro, C, Xue, L, Lavis, VR, Orlander, PR, Milewicz A, DM. An Aquaporin 2 Water Channel Gene Mutation Causing Nephrogenic Diabetes Insipidus in a Mexican Family:P1-707, 2002. e-Pub 2002.
Book Chapters
- Picolos MK, Lavis VR, Willerson JT. Endocrine Disorders and the Heart. In: Cardiovascular Medicine. Third Edition. Springer, 2295-2330, 2007.
- Lavis VR. Endocrine System. In: Heart Disease in Women. Churchill Livingstone, 25-35, 2002.
- Lavis VR, Willerson JT. Endocrine Disorders and the Heart. In: Cardiovascular Medicine. Second Edition. Churchill Livingstone, 1915-1937, 2000.
- Lavis VR. Pheochromocytoma. In: Saunders Manual of Medical Practice. W.B. Saunders, 867-869, 1999.
- Lavis VR, Fred HL. Hypoparathyroidism. In: Current Diagnosis 9. W.B. Saunders, 770-771, 1997.
- Lavis VR. Hypoglycemia. In: Magill's Survey of Science: Medical Science. Salem Press, 1994.
- Lavis VR, Mueller, SD, Willerson, JT. Endocrine Disorders and the Heart. In: Cardiovascular Medicine. Churchill Livingstone, 1607-1631, 1994.
- Thompson WJ, Lavis VR, Whalin ME, Strada SJ. Regulatory mechanisms of particulate cyclic nucleotide phosphodiesterases. In: Adv Second Messenger Phosphoprotein Res. Raven Press, 165-184, 1992.
- Lavis VR. Role of gluconeogenesis in diabetic hyperglycemia. In: Hormonal regulation of Gluconeogenesis. CRC Press, 65-76, 1986.
- Lavis VR. Psychiatric manifestations of endocrine disease in the elderly. In: Psychiatric Manifestations of Physical Disease in the Elderly. Raven Press, 59-81, 1980.
- Lavis VR. Antidiabetic agents. In: Neuropsychiatric Side Effects of Drugs in the Elderly. Raven Press, 151-171, 1979.
Letters to the Editor
- Lavis VR. Treatment of diabetic ketoacidosis. Diabetes Care 2(4): 385-7, 1979.
Patient Reviews
CV information above last modified July 22, 2026